Does the shingles jab slash your risk of dementia? Drugs giant GSK launches ground-breaking study that could save millions of Brits from developing the disease
The Shingles Vaccine and Dementia: A New Horizon The healthcare landscape is rapidly evolving with innovative studies that promise to reshape how we perceive preventive medicine. One of the most groundbreaking research initiatives is exploring whether the shingles vaccine, Shingrix, could significantly reduce the risk of dementia—a degenerative disease that affects millions worldwide. British pharmaceutical … Read more